Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026
The circSNX6 restricts dengue virus replication in association with PARP1 and ferroptosis.
Together, these results delineate the circRNA landscape across dengue disease progression and identify circSNX6 as a host factor that restricts DENV2 replication in part through suppression of the PARP1-ferroptosis axis.
TL;DR
Together, these results delineate the circRNA landscape across dengue disease progression and identify circSNX6 as a host factor that restricts DENV2 replication in part through suppression of the PARP1-ferroptosis axis.
Key findings
- In cultured cells, ferrostatin-1 reduced and erastin enhanced DENV2 replication; olaparib or ferrostatin-1 partially attenuated the proviral effects of circSNX6 knockdown, while erastin partially reversed the antiviral effect of circSNX6 overexpression.
- In mice, olaparib reduced serum and hepatic viral loads and attenuated hepatic pathology; ferrostatin-1 produced comparable effects, and erastin cotreatment partially diminished olaparib-mediated protection.
- Together, these results delineate the circRNA landscape across dengue disease progression and identify circSNX6 as a host factor that restricts DENV2 replication in part through suppression of the PARP1-ferroptosis axis.
What they did
Among these, hsa_circ_0031607 (circSNX6) was the sole circRNA linked to all three pathways and was upregulated in both dengue patients and DENV2-infected human umbilical vein endothelial cells (HUVECs). circSNX6 overexpression suppressed DENV2 replication, whereas its knockdown enhanced viral propagation. Mechanistically, circSNX6 localized to the cytoplasm and interacted with PARP1. DENV2 infection induced partial PARP1 redistribution from nucleus to cytoplasm. circSNX6 suppressed PARP1 expression; its knockdown increased global PARylation, accompanied by enhanced NRF2 PARylation and altered TFR1 and GPX4 expression.
Full abstract (original)
Background: Dengue virus (DENV) infection poses a persistent global health challenge with no specific antiviral therapy. Although circular RNAs (circRNAs) regulate antiviral immunity, their roles in DENV infection remain largely unexplored. Here, transcriptome sequencing of peripheral blood mononuclear cells (PBMCs) from dengue patients across disease phases and severities identified 15 circRNAs consistently dysregulated across all clinical stages, enriched in ferroptosis, glutathione metabolism, and endocytosis pathways.
What they did: Among these, hsa_circ_0031607 (circSNX6) was the sole circRNA linked to all three pathways and was upregulated in both dengue patients and DENV2-infected human umbilical vein endothelial cells (HUVECs). circSNX6 overexpression suppressed DENV2 replication, whereas its knockdown enhanced viral propagation. Mechanistically, circSNX6 localized to the cytoplasm and interacted with PARP1. DENV2 infection induced partial PARP1 redistribution from nucleus to cytoplasm. circSNX6 suppressed PARP1 expression; its knockdown increased global PARylation, accompanied by enhanced NRF2 PARylation and altered TFR1 and GPX4 expression.
Results & conclusions: In cultured cells, ferrostatin-1 reduced and erastin enhanced DENV2 replication; olaparib or ferrostatin-1 partially attenuated the proviral effects of circSNX6 knockdown, while erastin partially reversed the antiviral effect of circSNX6 overexpression. In mice, olaparib reduced serum and hepatic viral loads and attenuated hepatic pathology; ferrostatin-1 produced comparable effects, and erastin cotreatment partially diminished olaparib-mediated protection. Together, these results delineate the circRNA landscape across dengue disease progression and identify circSNX6 as a host factor that restricts DENV2 replication in part through suppression of the PARP1-ferroptosis axis.
Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2614593123 · PubMed 42814552.
Why it matters for pharma & biotech
- Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The work is preclinical. Results in animal or cell models frequently do not translate directly to human efficacy or safety.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Proceedings of the National Academy of Sciences (PNAS) study find?
Together, these results delineate the circRNA landscape across dengue disease progression and identify circSNX6 as a host factor that restricts DENV2 replication in part through suppression of the PARP1-ferroptosis axis.
What type of study is this?
It is a preclinical (animal / model) study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. Among these, hsa_circ_0031607 (circSNX6) was the sole circRNA linked to all three pathways and was upregulated in both dengue patients and DENV2-infected human umbilical vein endothelial cells (HUVECs).
Where can I read the original paper?
The original is at the publisher via DOI 10.1073/pnas.2614593123. PubMed ID: 42814552. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/the-circsnx6-restricts-dengue-virus-replication-in-association-with-parp-593123/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides